Thomas Lampron formally announced on LinkedIn this week that he is 'thrilled to join the powerhouse team at Revolution Medicines' as VP, global commercial pancreas lead, ending a 13-year career with Merck.
June 5, 2026 07:00 AM EDT
Peer Review
Novo vet Uli Stilz settles in at Flagship; Revolution Medicines welcomes commercial exec
Alex Hoffman
Copy Chief and News Editor
Silvia Luque announced on LinkedIn that she was named head of US marketing at Zealand Pharma. She had been executive director of…
As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. | As…
Ajaz Khan, M.D., a medical oncologist at City of Hope Chicago, was in the packed audience at this summer’s American Society of…
Michel Detheux has succeeded Rita Balice-Gordon as CEO of Danish neuro biotech Muna Therapeutics.
For Novo Nordisk, the launch of the company’s highly anticipated Wegovy pill at the start of the year—representing the first oral…
Following dynamite data that earned a standing ovation at the American Society of Clinical Oncology meeting in May, Revolution…
